Global Down Syndrome

Summer 2016

Issue link: https://viewer.e-digitaledition.com/i/728625

Contents of this Issue

Navigation

Page 9 of 31

Associate Professor of Pathology at the University of Colorado School of Medicine. THE ROLE OF ANGIOGENESIS Dr. Galambos and Dr. Ivy are among a small cadre of researchers conducting pioneering investigations into the genetics behind pulmonary hypertension in order to prevent children from succumbing to the disease. A key focus of this research is angiogenesis — the formation of new blood vessels from pre- existing blood vessels. Their research has shown that several anti-angiogenic factors are encoded on chromosome 21. People with Down syndrome are born with three copies this chromosome, instead of two, and therefore have a higher risk for such factors. These anti-angiogenic factors include: • Endostatin, which is encoded and cleaved from collagen 18a1 • Beta-amyloid protein, which is encoded and cleaved from amyloid-beta precursor protein • Regulator of calcineurin 1 (RCAN1), also known as Down syndrome critical region protein 1 "We believe that people with Down syndrome intrinsically carry compromised molecular signals that regulate vascular development," Dr. Galambos said. "Correcting those signals may result in diminished pulmonary morbidity and mortality." Currently, Dr. Galambos and his team are researching extra copies of genes on chromosome 21 involved in angiogenesis. Dr. Galambos hypothesizes that an excess of anti-angiogenic factors may block typical blood vessel development in all organs, including the lungs, in people with Down syndrome. "Underscoring our novel hypothesis is the fact that people with Down syndrome do not develop diseases that require significant vessel growth, including solid tumors, vascular malformations and diabetes," Dr. Galambos said. "Our goal is to explore the previously unrecognized role of chromosome 21-specific, anti-angiogenic factors in suppressing pulmonary angiogenesis." Initial data from Dr. Galambos' research is promising. His laboratory has already started generating data on the anti-angiogenic mechanisms that specifically drive pulmonary hypertension development. However, Dr. Galambos believes the implications of this research may extend far beyond lung development. "Proper angiogenic signals are required for the nerve growth that leads to complete intellectual development," Dr. Galambos said. "In Down syndrome and in Alzheimer's disease, nerve development and function is variably compromised. It is a very real possibility that impaired angiogenesis not only causes underdeveloped lungs, but also affects the development and function of neural networks in the brain in Down syndrome. This is a unique area of research that may potentially lead to curative angiogenesis-based therapies." Learn more about impactful research into the unique medical needs of people with Down syndrome at globaldownsyndrome.org/research-medical-care. CONTINUED FROM PAGE 9 SIGNS OF PULMONARY HYPERTENSION Children with pulmonary hypertension are often short of breath, and symptoms can be confused with other conditions, such as asthma. Other symptoms to look for include: • Blue tint to the lips, hands, or feet • Dizziness or fainting • Nausea • Chest pain • Fatigue • Coughing up blood • Recurrent respiratory infections Your child's doctor will help you determine whether your child has pulmonary hypertension. If the tests are positive, you will most likely be referred to a cardiologist or pulmonologist. Some tests that he/she may order include: • Blood tests • Chest X-ray • Computed tomography scan of the lungs, heart, and blood vessels • Electrocardiogram, also called an ECG or EKG • Echocardiogram, or ECHO • Sleep study • Ultrasound The Pediatric Pulmonary Hypertension Program at Children's Hospital Colorado has been treating children with the condition for more than 25 years. It's one of three pediatric programs in the U.S. to receive accreditation from the Pulmonary Hypertension Association to diagnose and care for medically complex patients. To learn more, visit bit.ly/global-pulmonary-hypertension. SUMMER2016 DOWN SYNDROME WORLD 10

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Summer 2016